{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:13:52Z","timestamp":1786745632249,"version":"build-2736575974"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":797,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"EFRE","doi-asserted-by":"publisher","award":["10169028"],"award-info":[{"award-number":["10169028"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["10169028"],"award-info":[{"award-number":["10169028"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Inflammation of the heart is a complex biological and pathophysiological response of the immune system to a variety of injuries leading to tissue damage and heart failure. MicroRNAs (miRNAs) emerge as pivotal players in the development of numerous diseases, suggesting their potential utility as biomarkers for inflammation and as viable candidates for therapeutic interventions. The primary aim of this investigation was to pinpoint and assess particular miRNAs in individuals afflicted by virus-negative inflammatory dilated cardiomyopathy (DCMi).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The study involved the analysis of 152 serum samples sourced from patients diagnosed with unexplained heart failure through endomyocardial biopsy. Among these samples, 38 belonged to DCMi patients, 24 to DCM patients, 44 to patients displaying inflammation alongside diverse viral infections, and 46 to patients solely affected by viral infections without concurrent inflammation. Additionally, serum samples from 10 healthy donors were included. The expression levels of 754 distinct miRNAs were evaluated using TaqMan OpenArray. MiR-1, miR-23, miR-142-5p, miR-155, miR-193, and miR-195 exhibited exclusive down-regulation solely in DCMi patients (P &amp;lt; 0.005). These miRNAs enabled effective differentiation between individuals with inflammation unlinked to viruses (DCMi) and all other participant groups (P &amp;lt; 0.005), boasting a specificity surpassing 86%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The identification of specific miRNAs offers a novel diagnostic perspective for recognizing intramyocardial inflammation within virus-negative DCMi patients. Furthermore, these miRNAs hold promise as potential candidates for tailored therapeutic strategies in the context of virus-negative DCMi.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14523","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T01:44:25Z","timestamp":1694137465000},"page":"3410-3418","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNAs As Novel Biomarkers and Potential Therapeutic Options for Inflammatory Cardiomyopathy"],"prefix":"10.1093","volume":"10","author":[{"given":"Ganna","family":"Aleshcheva","sequence":"first","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Moltkestr. 31, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baumeier","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Moltkestr. 31, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Harms","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Moltkestr. 31, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-Thomas","family":"Bock","sequence":"additional","affiliation":[{"name":"Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Escher","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Moltkestr. 31, Berlin ,","place":["Germany"]},{"name":"Department of Cardiology, Campus Virchow, Charit\u00e9 \u2013 University Hospital Berlin , Berlin ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Peter","family":"Schultheiss","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Moltkestr. 31, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"2026012113205885100_ehf214523-bib-0001","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026012113205885100_ehf214523-bib-0002","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00428-019-02615-8","article-title":"The spectrum of myocarditis: From pathology to the clinics","volume":"475","author":"Leone","year":"2019","journal-title":"Virchows Arch"},{"key":"2026012113205885100_ehf214523-bib-0003","doi-asserted-by":"publisher","first-page":"2648a","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012113205885100_ehf214523-bib-0004","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/eurheartj\/ehaa841","article-title":"Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences","volume":"42","author":"Verdonschot","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113205885100_ehf214523-bib-0005","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15190\/d.2015.34","article-title":"Inflammation between defense and disease: Impact on tissue repair and chronic sickness","volume":"3","author":"Liehn","year":"2015","journal-title":"Discoveries"},{"key":"2026012113205885100_ehf214523-bib-0006","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"2026012113205885100_ehf214523-bib-0007","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bone.2016.12.007","article-title":"Role of the plasma cascade systems in ischemia\/reperfusion injury of bone","author":"Zhang","year":"2017","journal-title":"Bone"},{"key":"2026012113205885100_ehf214523-bib-0008","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/cshperspect.a016345","article-title":"Inflammation and the blood microvascular system","author":"Pober","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026012113205885100_ehf214523-bib-0009","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation","volume":"119","author":"Dick","year":"2016","journal-title":"Circ Res American Heart Association"},{"key":"2026012113205885100_ehf214523-bib-0010","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1253\/circj.CJ-21-0529","article-title":"Myocardial T-lymphocytes as a prognostic risk-stratifying marker of dilated cardiomyopathy\u2014Results of the multicenter registry to investigate inflammatory cell infiltration in dilated cardiomyopathy in tissues of endomyocardial biopsy (INDICATE study)","volume":"86","author":"Ohta-Ogo","year":"2022","journal-title":"Circ J"},{"key":"2026012113205885100_ehf214523-bib-0011","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.2009.05121.x","article-title":"MicroRNAs of the immune system: Roles in inflammation and cancer","volume":"1183","author":"Davidson-Moncada","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2026012113205885100_ehf214523-bib-0012","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/TP.0b013e3181e913c2","article-title":"MicroRNAs: Small RNAs with big effects","volume":"90","author":"Anglicheau","year":"2010","journal-title":"Transplantation"},{"key":"2026012113205885100_ehf214523-bib-0013","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101712","article-title":"MicroRNA in control of gene expression: An overview of nuclear functions","author":"Catalanotto","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026012113205885100_ehf214523-bib-0014","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/ATVBAHA.112.300068","article-title":"MicroRNAs in immune response and macrophage polarization","volume":"33","author":"Liu","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol American Heart Association"},{"key":"2026012113205885100_ehf214523-bib-0015","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fimmu.2018.01377","article-title":"Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment","volume":"9","author":"Tahamtan","year":"2018","journal-title":"Front Immunol"},{"key":"2026012113205885100_ehf214523-bib-0016","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/biom12101476","article-title":"A systematic review of miRNA and cfDNA as potential biomarkers for liquid biopsy in myocarditis and inflammatory dilated cardiomyopathy","volume":"12","author":"Lewandowski","year":"2022","journal-title":"Biomolecules"},{"key":"2026012113205885100_ehf214523-bib-0017","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","article-title":"microRNA regulation of inflammatory responses","volume":"30","author":"O'Connell","year":"2012","journal-title":"Annu Rev Immunol Annual Reviews"},{"key":"2026012113205885100_ehf214523-bib-0018","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/leu.2011.356","article-title":"MicroRNAs in inflammation and immune responses","volume":"26","author":"Contreras","year":"2012","journal-title":"Leukemia"},{"key":"2026012113205885100_ehf214523-bib-0019","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri2634","article-title":"Transcriptional control of the inflammatory response","volume":"9","author":"Medzhitov","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2026012113205885100_ehf214523-bib-0020","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ehf2.13090","article-title":"MiRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and\/or virally-induced cardiomyopathies","volume":"8","author":"Aleshcheva","year":"2020","journal-title":"ESC Hear Fail"},{"key":"2026012113205885100_ehf214523-bib-0021","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymthe.2019.07.001","article-title":"Circular RNAs: A novel class of functional RNA molecules with a therapeutic perspective","volume":"27","author":"Santer","year":"2019","journal-title":"Mol Ther"},{"key":"2026012113205885100_ehf214523-bib-0022","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ Res American Heart Association"},{"key":"2026012113205885100_ehf214523-bib-0023","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030452","article-title":"miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis","volume":"11","author":"Kmio\u0142ek","year":"2022","journal-title":"Cell"},{"key":"2026012113205885100_ehf214523-bib-0024","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152332","article-title":"MicroRNAs and their big therapeutic impacts: Delivery strategies for cancer intervention","volume":"11","author":"Holjencin","year":"2022","journal-title":"Cell"},{"key":"2026012113205885100_ehf214523-bib-0025","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113205885100_ehf214523-bib-0026","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"key":"2026012113205885100_ehf214523-bib-0027","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.3390\/cancers13112680","article-title":"MicroRNA therapeutics in cancer: Current advances and challenges","volume":"13","author":"Reda El Sayed","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026012113205885100_ehf214523-bib-0028","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.tig.2018.12.005","article-title":"miRNA targeting: Growing beyond the seed","volume":"35","author":"Chipman","year":"2019","journal-title":"Trends Genet Elsevier"},{"key":"2026012113205885100_ehf214523-bib-0029","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/DDDT.S288859","article-title":"The risks of miRNA therapeutics: In a drug target perspective","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"2026012113205885100_ehf214523-bib-0030","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.addr.2017.12.011","article-title":"miRNA delivery for skin wound healing","volume":"129","author":"Meng","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"2026012113205885100_ehf214523-bib-0031","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00395-013-0372-y","article-title":"A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression","volume":"108","author":"Kuhl","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"2026012113205885100_ehf214523-bib-0032","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5543\/tkda.2015.47750","article-title":"Myocarditis and inflammatory cardiomyopathy: From diagnosis to treatment","volume":"43","author":"Escher","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2026012113205885100_ehf214523-bib-0033","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction","volume":"111","author":"Kuhl","year":"2005","journal-title":"Circulation"},{"key":"2026012113205885100_ehf214523-bib-0034","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2014.14010","article-title":"Viral myocarditis","volume":"144","author":"K\u00fchl","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"2026012113205885100_ehf214523-bib-0035","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction","volume":"111","author":"K\u00fchl","year":"2005","journal-title":"Circulation Lippincott Williams & Wilkins"},{"key":"2026012113205885100_ehf214523-bib-0036","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126423","article-title":"MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer's disease","volume":"10","author":"Denk","year":"2015","journal-title":"PLoS One Public Library of Science"},{"key":"2026012113205885100_ehf214523-bib-0037","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026012113205885100_ehf214523-bib-0038","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ Hear Fail American Heart Association"},{"key":"2026012113205885100_ehf214523-bib-0039","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","article-title":"Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-\u03b2 treatment in patients with chronic viral cardiomyopathy","volume":"105","author":"Schultheiss","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026012113205885100_ehf214523-bib-0040","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004228","article-title":"Immunosuppressive therapy improves both short- and long-term prognosis in patients with virus-negative nonfulminant inflammatory cardiomyopathy","volume":"11","author":"Merken","year":"2018","journal-title":"Circ Hear Fail American Heart Association"},{"key":"2026012113205885100_ehf214523-bib-0041","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur Heart J"},{"key":"2026012113205885100_ehf214523-bib-0042","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/08820139.2017.1373901","article-title":"Regulatory roles of micro-RNAs in T cell autoimmunity","volume":"46","author":"Esmailzadeh","year":"2017","journal-title":"Immunol Invest Taylor & Francis"},{"key":"2026012113205885100_ehf214523-bib-0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110903","article-title":"miR-1: A comprehensive review of its role in normal development and diverse disorders","volume":"132","author":"Safa","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2026012113205885100_ehf214523-bib-0044","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2147\/JIR.S362368","article-title":"Inhibition of miRNA-1-mediated inflammation and autophagy by astragaloside IV improves lipopolysaccharide-induced cardiac dysfunction in rats","volume":"15","author":"Wang","year":"2022","journal-title":"J Inflamm Res"},{"key":"2026012113205885100_ehf214523-bib-0045","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.prp.2018.09.004","article-title":"miR-23 regulates cell proliferation and apoptosis of vascular smooth muscle cells in coronary heart disease","volume":"214","author":"Liu","year":"2018","journal-title":"Pathol Res Pract"},{"key":"2026012113205885100_ehf214523-bib-0046","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.26355\/eurrev_201905_17950","article-title":"MiR-23 enhances cardiac fibroblast proliferation and suppresses fibroblast apoptosis via targeting TGF-\u03b21 in atrial fibrillation","volume":"23","author":"Yu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026012113205885100_ehf214523-bib-0047","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12974-017-0832-7","article-title":"MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis","volume":"14","author":"Talebi","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2026012113205885100_ehf214523-bib-0048","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819892264","article-title":"MiR-142-5p acts as a significant regulator through promoting proliferation, invasion, and migration in breast cancer modulated by targeting SORBS1","volume":"18","author":"Yu","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"2026012113205885100_ehf214523-bib-0049","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jir.2018.0155","article-title":"MicroRNA-155: A master regulator of inflammation","volume":"39","author":"Mahesh","year":"2019","journal-title":"J Interf Cytokine Res Mary Ann Liebert, Inc."},{"key":"2026012113205885100_ehf214523-bib-0050","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-021-03500-0","article-title":"Role of endothelial microRNA 155 on capillary leakage in systemic inflammation","volume":"25","author":"Etzrodt","year":"2021","journal-title":"Crit Care"},{"key":"2026012113205885100_ehf214523-bib-0051","doi-asserted-by":"publisher","DOI":"10.1038\/srep39405","article-title":"MiR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"2026012113205885100_ehf214523-bib-0052","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155\u2014At the critical interface of innate and adaptive immunity in arthritis","volume":"8","author":"Alivernini","year":"2018","journal-title":"Front Immunol"},{"key":"2026012113205885100_ehf214523-bib-0053","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: A typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"2026012113205885100_ehf214523-bib-0054","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3892\/etm.2018.7019","article-title":"Role of miR-155 in immune regulation and its relevance in oral lichen planus (review)","volume":"17","author":"Tao","year":"2019","journal-title":"Exp Ther Med"},{"key":"2026012113205885100_ehf214523-bib-0055","doi-asserted-by":"publisher","first-page":"16861","DOI":"10.1002\/jcp.28368","article-title":"miR-193: A new weapon against cancer","volume":"234","author":"Khordadmehr","year":"2019","journal-title":"J Cell Physiol John Wiley & Sons, Ltd"},{"key":"2026012113205885100_ehf214523-bib-0056","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.biopha.2018.12.106","article-title":"Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy","volume":"111","author":"Izadpanah","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026012113205885100_ehf214523-bib-0057","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14761-8","article-title":"Abstract P1109: Investigating the role of human conserved microrna-193 in the aging Drosophila heart","volume":"131","author":"Hohman","year":"2022","journal-title":"Circ Res American Heart Association"},{"key":"2026012113205885100_ehf214523-bib-0058","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.2147\/OTT.S183600","article-title":"MicroRNA-195: A review of its role in cancers","volume":"11","author":"Yu","year":"2018","journal-title":"Onco Targets Ther Dove Medical Press"},{"key":"2026012113205885100_ehf214523-bib-0059","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188530","article-title":"miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells","volume":"12","author":"Br\u00e1s","year":"2017","journal-title":"PLoS ONE"},{"key":"2026012113205885100_ehf214523-bib-0060","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat Rev Genet"},{"key":"2026012113205885100_ehf214523-bib-0061","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccep.2021.11.001","article-title":"Prevalence and clinical implications of COVID-19 myocarditis","volume":"14","author":"Chimenti","year":"2022","journal-title":"Card Electrophysiol Clin Elsevier"},{"key":"2026012113205885100_ehf214523-bib-0062","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00059-012-3656-3","article-title":"miRNA as activity markers in Parvo B19 associated heart disease","volume":"37","author":"K\u00fchl","year":"2012","journal-title":"Herz"},{"key":"2026012113205885100_ehf214523-bib-0063","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/CIRCHEARTFAILURE.114.001475","article-title":"Differential cardiac microRNA expression predicts the clinical course in human enterovirus cardiomyopathy","volume":"8","author":"Kuehl","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026012113205885100_ehf214523-bib-0064","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: From cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet Elsevier"},{"key":"2026012113205885100_ehf214523-bib-0065","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2022.839945","article-title":"Dysregulation of survivin-targeting microRNAs in autoimmune diseases: New perspectives for novel therapies","volume":"13","author":"Shomali","year":"2022","journal-title":"Front Immunol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/6\/3410\/64699304\/eschf_10_6_3410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/6\/3410\/64699304\/eschf_10_6_3410.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:25:34Z","timestamp":1769019934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/6\/3410\/8284375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,9,7]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14523","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"2023-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}